TU/e spin-off STENTit awarded for two prizes during the Global Entrepreneurship Summit
Prince Constantijn and Miss Ivanka Trump award STENTiT for both Outstanding Women Entrepreneur and GIST Health Runner-Up during the GES.
As winner of the Academic Start-Up Competition, STENTiT was given the opportunity to present its technology to a global audience at the Global Entrepreneurship Summit (GES) in The Hague on June 4.
The TU/e spin-off participated in the Global Innovation through Science & Technology (GIST) Catalyst pitch competition, organised in collaboration with the Dutch Academic Start-Up Competition. STENTiT has won both the Outstanding Women Entrepreneur in Science and Technology award, as well as the Runner-Up prize in the Health focus area.
STENTiT founders Bart Sanders and Sol Cabrera developed a technology to restore diseased arteries using regenerative stents. These unique bioresorbable devices allow for minimally invasive implantation to provide instant support to the lesion while triggering a natural healing response using the patient’s own circulating blood cells to reconstruct a whole new artery. Vascular regeneration will improve long-term clinical outcomes for millions of patients while reducing health-care costs.
The GIST Catalyst competition began with over 4,000 applications from all over the world, which narrowed down to a list of top 30 companies giving the opportunity to pitch their business at the GES 2019, divided over the 5 focus sectors including Health.
In addition to exposure on this global event, STENTiT has won $38.000 in credits from private sector sponsors IBM, Google and AWS, where in addition a booth at CES will be provided and a 1-on-1 mentorship session with the Silicon Valley Bank.
Watch the video of the award ceremony by clicking on the Youtube icon below.